Finasteride Results Timeline: What to Expect at 3, 6, 12, and 24 Months

The most common question from men starting finasteride is: when will I see results? The honest answer, grounded in clinical trial data: meaningful hair stabilization typically occurs within 3–6 months, visible regrowth within 6–12 months, and peak response at 12–24 months of continuous daily use. Finasteride does not work overnight — it works through the biology of the hair growth cycle, which takes months to turn over.

Why Results Take Months: The Hair Cycle Biology

Finasteride reduces DHT within hours of the first dose. But visible hair results don’t follow immediately — for a fundamental biological reason. Hair follicles cycle through three phases:

• Anagen (growth phase): Active growth, lasting 2–6 years in a healthy scalp follicle; shortened to weeks or months in DHT-miniaturized AGA follicles
• Catagen (transition phase): ~2 weeks; follicle retracts
• Telogen (resting/shedding phase): 2–4 months; old hair is shed and the cycle restarts

When finasteride reduces DHT, miniaturized follicles begin to recover — but they have to complete their current cycle first before growing a new, thicker hair. This biological lag is why patience is essential: the drug may be working weeks before any visible improvement appears.

Month-by-Month Timeline

Weeks 1–8: Initial Phase (No Visible Change; Possible Shed)

In the first 1–2 months, there is typically no visible improvement. Some men notice increased shedding during this window — the so-called “finasteride shed” or “initial shed.” This occurs because finasteride’s DHT suppression triggers resting follicles to re-enter the growth cycle simultaneously, temporarily increasing the number of hairs in the shedding (telogen) phase.

Is increased shedding a bad sign? No. In most cases, the finasteride shed is a normal and expected response reflecting follicular activity, not failure. It typically peaks between weeks 2 and 8 and resolves. Men who experience this shed often go on to achieve good results. However, shedding that is severe, prolonged beyond 3–4 months, or associated with scalp symptoms should be evaluated by a dermatologist.

Months 3–6: Stabilization

By month 3–6, the majority of men notice that the rate of hair loss has slowed or stopped. This stabilization — not new growth — is typically the first clinical sign that finasteride is working. DHT levels in the scalp are now significantly reduced; follicles that have been suppressed are beginning to recover and extend their anagen phase.

In the pivotal Kaufman 1998 trials, 83% of finasteride-treated men showed maintained or improved hair count at 12 months, compared to 28% on placebo. The stabilization phase corresponds to the transition from net loss to net maintenance.

Months 6–12: Visible Improvement

For most responding men, this is the window of most noticeable visible improvement. Follicles that were miniaturized are now producing fuller, thicker, longer terminal hairs. Hair density and caliber increase, often most visibly at the vertex (crown) where finasteride’s evidence is strongest.

From the pivotal trial data:

• At 12 months, men on finasteride had a mean of +7.1 hairs/cm² vs. a loss of 10.6 hairs/cm² in the placebo group
• 48% of men showed visible hair growth improvement by investigator assessment vs. 7% on placebo

Months 12–24: Peak Response

Clinical trial data indicates that peak hair count benefit is typically reached between 12 and 24 months of continuous treatment. After 12 months, some men continue to improve gradually; others maintain their gains without further increase. This is the period when photographs are most striking compared to pre-treatment baseline.

Men who had been on placebo in the pivotal trials and switched to finasteride at 12 months improved significantly but never reached the hair count of men who had been on finasteride since the beginning — reinforcing that early treatment produces the best outcomes.

Year 2 and Beyond: Long-Term Maintenance

With continuous daily use, clinical benefit is maintained for as long as the drug is taken. The 5-year extension study showed that hair count remained above baseline throughout 5 years in the finasteride group. A 10-year prospective study (Rossi et al., 2011) found that 99.1% of patients maintained or increased their hair count with continuous use over a decade.

The reason long-term benefit requires ongoing treatment: finasteride suppresses DHT only while it is taken. Stopping finasteride allows DHT to return to baseline within weeks, and hair loss typically resumes within 6–12 months.

Summary Timeline Table

Timepoint	What typically happens	Clinical trial data reference
Weeks 1–2	DHT suppressed within hours; no visible change yet	Dallob et al., 1994 (DHT reduction)
Weeks 2–8	Possible initial shedding (normal); still no visible improvement	Clinical observation; expected pharmacologic effect
Months 3–6	Hair loss stabilizes for most responders; shedding normalizes	Kaufman et al., 1998 (83% stabilized at 12 mo)
Months 6–12	Visible improvement in density and caliber for ~48% of men	Kaufman et al., 1998 (48% improved, vertex)
Months 12–24	Peak hair count; continued improvement possible	Kaufman et al., 1999 (5-year extension)
Year 2+ (continuous use)	Maintained benefit; ongoing protection against further loss	Rossi et al., 2011 (10-year study)
After stopping	Hair loss resumes to pre-treatment trajectory within 6–12 months	Propecia Prescribing Information

What Determines Your Individual Response?

Not all men respond equally to finasteride. Factors associated with better response include:

• Starting early: Men who begin treatment at Norwood–Hamilton Type II–III (early diffuse thinning, mild vertex loss) have the most reversible miniaturization and the best prognosis
• Younger age: Younger men generally show better response rates, likely because fewer follicles have been permanently lost
• Vertex and mid-scalp pattern: Finasteride has the strongest evidence for vertex AGA; frontal hairline responses are generally more modest
• Baseline hair density: Men with higher baseline miniaturized (but not permanently lost) follicle populations have more follicles that can recover

If you have not seen any benefit after 12 months of daily finasteride, further benefit is unlikely. Discussing options with a dermatologist — including adding minoxidil, switching to dutasteride (off-label for AGA), or evaluating surgical options — is appropriate at that point.

Frequently Asked Questions

Is it normal to not see results at 3 months?

Yes. Seeing no visible improvement at 3 months is completely normal. The 3-month mark is typically still in the stabilization window — the drug is reducing DHT and preventing further loss, but visible regrowth has not yet had time to develop. Most visible improvement occurs between months 6 and 12. Give finasteride at least 12 months of consistent daily use before evaluating whether it is working for you.

I am shedding more hair since starting finasteride. Is that normal?

A temporary increase in shedding 2–8 weeks after starting finasteride is a recognized and common phenomenon (“initial shed” or “finasteride shed”). It occurs because finasteride’s DHT suppression causes telogen follicles to transition back into the anagen growth phase, temporarily increasing the number of hairs cycling out. This typically resolves within 2–4 months and is not a sign that the drug is failing. However, if shedding is severe, involves the entire scalp, or does not resolve by month 4, see a dermatologist to rule out other causes of hair loss.

How do I know if finasteride is working?

The earliest reliable sign is stabilization — hair loss slowing or stopping. The most objective way to track this is standardized photography taken under consistent lighting and positioning at 0, 6, and 12 months. Hair count assessments with a trichoscope (performed by a dermatologist) provide quantitative data. Most men experience noticeable visual improvement by 12 months; a 12-month assessment with before and after photos is the standard clinical benchmark.

Sources

• Kaufman KD, et al. “Finasteride in the treatment of men with androgenetic alopecia.” J Am Acad Dermatol. 1998;39(4):578–589.
• Kaufman KD, et al. “Long-term (5-year) multinational experience with finasteride 1 mg.” Eur J Dermatol. 2002;12(1):38–49.
• Rossi A, et al. “Finasteride, 1 mg daily: 10-year follow-up.” Dermatol Ther. 2011;24(4):455–461.
• Dallob AL, et al. “The effect of finasteride on scalp skin testosterone and DHT.” J Clin Endocrinol Metab. 1994;79(3):703–706.